13,14-dihydro-15-keto PGF2a

Modify Date: 2024-01-12 11:19:55

13,14-dihydro-15-keto PGF2a Structure
13,14-dihydro-15-keto PGF2a structure
Common Name 13,14-dihydro-15-keto PGF2a
CAS Number 27376-76-7 Molecular Weight 354.481
Density 1.1±0.1 g/cm3 Boiling Point 543.0±40.0 °C at 760 mmHg
Molecular Formula C20H34O5 Melting Point N/A
MSDS N/A Flash Point 296.2±23.8 °C

 Use of 13,14-dihydro-15-keto PGF2a


13,14-Dihydro-15-keto PGF2a is an endogenous metabolite present in Blood that can be used for the research of Pregnancy[1][2].

 Names

Name 13,14-dihydro-15-keto-PGF2α
Synonym More Synonyms

 13,14-dihydro-15-keto PGF2a Biological Activity

Description 13,14-Dihydro-15-keto PGF2a is an endogenous metabolite present in Blood that can be used for the research of Pregnancy[1][2].
Related Catalog
In Vitro Endogenous metabolites is defined as those that are annotated by Kyoto Encyclopedia of Genes and Genomes as substrates or products of the ~1900 metabolic enzymes encoded in our genome. It is clear in the body of literature that there are documented toxic properties for many of these metabolites[1].
References

[1]. Lee N, et al. Endogenous toxic metabolites and implications in cancer therapy. Oncogene. 2020 Aug;39(35):5709-5720.  

[2]. The dynamic changes of several reproductive hormones during termination of early pregnancy by RU486 in combination with PG-05 in Chinese women. Adv Contracept. 1988 Dec;4(4):319-26.   

 Chemical & Physical Properties

Density 1.1±0.1 g/cm3
Boiling Point 543.0±40.0 °C at 760 mmHg
Molecular Formula C20H34O5
Molecular Weight 354.481
Flash Point 296.2±23.8 °C
Exact Mass 354.240631
PSA 94.83000
LogP 2.13
Vapour Pressure 0.0±3.3 mmHg at 25°C
Index of Refraction 1.512

 MSDS


SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product identifiers
Product name: 13,14-Dihydro-15-ketoprostaglandin F2α
REACH No.: A registration number is not available for this substance as the substance
or its uses are exempted from registration, the annual tonnage does not
require a registration or the registration is envisaged for a later
registration deadline.
CAS-No.: 27376-76-7
Relevant identified uses of the substance or mixture and uses advised against
Identified uses: Laboratory chemicals, Manufacture of substances



SECTION 2: Hazards identification
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008
Acute toxicity, Inhalation (Category 4), H332
Acute toxicity, Dermal (Category 4), H312
Acute toxicity, Oral (Category 4), H302
For the full text of the H-Statements mentioned in this Section, see Section 16.
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Xn HarmfulR20/21/22
For the full text of the R-phrases mentioned in this Section, see Section 16.
Label elements
Labelling according Regulation (EC) No 1272/2008
Pictogram
Signal wordWarning
Hazard statement(s)
H302Harmful if swallowed.
H312Harmful in contact with skin.
H332Harmful if inhaled.
Precautionary statement(s)
P280Wear protective gloves/ protective clothing.
Supplemental Hazardnone
Statements
Other hazards - none

SECTION 3: Composition/information on ingredients
Substances
Formula: C20H34O5
Molecular Weight: 354,48 g/mol
CAS-No.: 27376-76-7
Hazardous ingredients according to Regulation (EC) No 1272/2008
ComponentClassificationConcentration
13,14-Dihydro-15-ketoprostaglandin F2α
Acute Tox. 4; H302, H312,-
H332
Hazardous ingredients according to Directive 1999/45/EC
ComponentClassificationConcentration
13,14-Dihydro-15-ketoprostaglandin F2α
Xn, R20/21/22-
For the full text of the H-Statements and R-Phrases mentioned in this Section, see Section 16

SECTION 4: First aid measures
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in
section 11
Indication of any immediate medical attention and special treatment needed
no data available

SECTION 5: Firefighting measures
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

SECTION 6: Accidental release measures
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid breathing vapors, mist or gas. Ensure adequate ventilation.
For personal protection see section 8.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Soak up with inert absorbent material and dispose of as hazardous waste. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

SECTION 7: Handling and storage
Precautions for safe handling
Avoid contact with skin and eyes. Avoid inhalation of vapour or mist.
Normal measures for preventive fire protection.
For precautions see section 2.2.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Containers which are
opened must be carefully resealed and kept upright to prevent leakage.
Recommended storage temperature: -20 °C
Specific end use(s)
A part from the uses mentioned in section 1.2 no other specific uses are stipulated

SECTION 8: Exposure controls/personal protection
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Face shield and safety glasses Use equipment for eye protection tested and approved under
appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Where risk assessment shows air-purifying respirators are appropriate use a full-face respirator
with multi-purpose combination (US) or type ABEK (EN 14387) respirator cartridges as a backup
to engineering controls. If the respirator is the sole means of protection, use a full-face supplied air
respirator. Use respirators and components tested and approved under appropriate government
standards such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Do not let product enter drains.

SECTION 9: Physical and chemical properties
Information on basic physical and chemical properties
a) AppearanceForm: liquid
b) Odourno data available
c) Odour Thresholdno data available
d) pHno data available
e) Melting point/freezingno data available
point
f) Initial boiling point and no data available
boiling range
g) Flash pointno data available
h) Evaporation rateno data available
i) Flammability (solid, gas) no data available
j) Upper/lowerno data available
flammability or
explosive limits
k) Vapour pressureno data available
l) Vapour densityno data available
m) Relative densityno data available
n) Water solubilityno data available
o) Partition coefficient: n- no data available
octanol/water
p) Auto-ignitionno data available
temperature
q) Decompositionno data available
temperature
r) Viscosityno data available
s) Explosive propertiesno data available
t) Oxidizing propertiesno data available
Other safety information
no data available

SECTION 10: Stability and reactivity
Reactivity
no data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available
In the event of fire: see section 5

SECTION 11: Toxicological information
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC:No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Additional Information
RTECS: Not available
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.

SECTION 12: Ecological information
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted
Other adverse effects
no data available

SECTION 13: Disposal considerations
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed
professional waste disposal service to dispose of this material.
Contaminated packaging
Dispose of as unused product.

SECTION 14: Transport information
UN number
ADR/RID: -IMDG: -IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA:Not dangerous goods
Transport hazard class(es)
ADR/RID: -IMDG: -IATA: -
Packaging group
ADR/RID: -IMDG: -IATA: -
Environmental hazards
ADR/RID: noIMDG Marine Pollutant: noIATA: no
Special precautions for user
no data available

SECTION 15: Regulatory information
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
no data available
Chemical Safety Assessment
For this product a chemical safety assessment was not carried out

SECTION 16: Other information
Full text of H-Statements referred to under sections 2 and 3.
Acute Tox.Acute toxicity
H302Harmful if swallowed.
H312Harmful in contact with skin.
H332Harmful if inhaled.
Full text of R-phrases referred to under sections 2 and 3
XnHarmful
R20/21/22Harmful by inhalation, in contact with skin and if swallowed.
Further information
Copyright 2013 Co. LLC. License granted to make unlimited paper copies for internal use
only.
The above information is believed to be correct but does not purport to be all inclusive and shall be
used only as a guide. The information in this document is based on the present state of our knowledge
and is applicable to the product with regard to appropriate safety precautions. It does not represent any
guarantee of the properties of the product. Corporation and its Affiliates shall not be held
liable for any damage resulting from handling or from contact with the above product. See
and/or the reverse side of invoice or packing slip for additional terms and conditions of sale.

 Safety Information

Hazard Codes Xn: Harmful;
Risk Phrases 20/21/22
Safety Phrases 22-36

 Synthetic Route

~59%

13,14-dihydro-15-keto PGF2a Structure

13,14-dihydro-1...

CAS#:27376-76-7

Literature: Marczak, S.; Wicha, J. Synthetic Communications, 1989 , vol. 19, # 3and4 p. 633 - 640

~%

13,14-dihydro-15-keto PGF2a Structure

13,14-dihydro-1...

CAS#:27376-76-7

Literature: Marczak, S.; Wicha, J. Synthetic Communications, 1989 , vol. 19, # 3and4 p. 633 - 640

 Precursor & DownStream

Precursor  2

DownStream  0

 Synonyms

Prost-5-en-1-oic acid, 9,11-dihydroxy-15-oxo-, (5Z,9α,11α)-
13,14-DIHYDRO-15-KETO PROSTAGLANDIN F2ALPHA
13,14-dihydro-15-keto PGF2a
13,14-Dihydro-15-keto-pgf2α
Prostaglandin FM
13,14-Dihydro-15-ketoprostaglandin f
15-Keto-13,14-dihydro-pgf2alpha
13,14-Dihydro-15-oxoprostaglandin f
13,14-Dihydro-15-ketodinoprost
PGFM
(5Z,9α,11α)-9,11-Dihydroxy-15-oxoprost-5-en-1-oic acid
13,14-dihydro-15-keto-PGF2alpha
Top Suppliers:I want be here


Get all suppliers and price by the below link:

13,14-dihydro-15-keto PGF2a suppliers

13,14-dihydro-15-keto PGF2a price